Oncology Today with Dr Neil Love

348 Epizód

1. Peripheral T-Cell Lymphoma

   Közzétéve: 2024. 10. 16.
2. The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer

   Közzétéve: 2024. 10. 15.
3. Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series

   Közzétéve: 2024. 10. 10.
4. The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR

   Közzétéve: 2024. 10. 08.
5. The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations

   Közzétéve: 2024. 10. 01.
6. Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer

   Közzétéve: 2024. 09. 24.
7. Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers

   Közzétéve: 2024. 09. 20.
8. Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors

   Közzétéve: 2024. 09. 17.
9. Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers

   Közzétéve: 2024. 09. 11.
10. Optimizing the Management of Dedifferentiated Liposarcoma

    Közzétéve: 2024. 09. 09.
11. Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer

    Közzétéve: 2024. 09. 06.
12. Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation

    Közzétéve: 2024. 09. 04.
13. Management of Metastatic Urothelial Bladder Cancer

    Közzétéve: 2024. 08. 30.
14. Special Edition — Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

    Közzétéve: 2024. 08. 28.
15. An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer

    Közzétéve: 2024. 08. 23.
16. An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer

    Közzétéve: 2024. 08. 21.
17. Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer

    Közzétéve: 2024. 08. 20.
18. Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer

    Közzétéve: 2024. 08. 16.
19. Novel Agents and Strategies in Lung Cancer

    Közzétéve: 2024. 08. 13.
20. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma

    Közzétéve: 2024. 08. 09.